108 related articles for article (PubMed ID: 14991766)
1. TAK-778 enhances osteoblast differentiation of human bone marrow cells via an estrogen-receptor-dependent pathway.
Rosa AL; Beloti MM
J Cell Biochem; 2004 Mar; 91(4):749-55. PubMed ID: 14991766
[TBL] [Abstract][Full Text] [Related]
2. TAK-778 enhances osteoblast differentiation of human bone marrow cells.
Rosa AL; Beloti MM
J Cell Biochem; 2003 Aug; 89(6):1148-53. PubMed ID: 12898513
[TBL] [Abstract][Full Text] [Related]
3. The effect of TAK-778 on gene expression of osteoblastic cells is mediated through estrogen receptor.
Bellesini LS; Beloti MM; Crippa GE; Bombonato-Prado KF; Junta CM; Marques MM; Passos GA; Rosa AL
Exp Biol Med (Maywood); 2009 Feb; 234(2):190-9. PubMed ID: 19064943
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of osteogenesis in vitro and in vivo by a novel osteoblast differentiation promoting compound, TAK-778.
Notoya K; Nagai H; Oda T; Gotoh M; Hoshino T; Muranishi H; Taketomi S; Sohda T; Makino H
J Pharmacol Exp Ther; 1999 Sep; 290(3):1054-64. PubMed ID: 10454478
[TBL] [Abstract][Full Text] [Related]
5. Chronic ethanol intake inhibits in vitro osteogenesis induced by osteoblasts differentiated from stem cells.
Rosa ML; Beloti MM; Prando N; Queiroz RH; de Oliveira PT; Rosa AL
J Appl Toxicol; 2008 Mar; 28(2):205-11. PubMed ID: 17582586
[TBL] [Abstract][Full Text] [Related]
6. TAK-778 enhances osteoblast differentiation of human bone marrow cells cultured on titanium.
Rosa AL; Beloti MM
Biomaterials; 2003 Aug; 24(17):2927-32. PubMed ID: 12742732
[TBL] [Abstract][Full Text] [Related]
7. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts.
Heino TJ; Hentunen TA; Väänänen HK
Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534
[TBL] [Abstract][Full Text] [Related]
8. Participation of estrogen receptors in the enhancement of osteoblast differentiation by TAK-778.
Beloti MM; Bellesini LS; de Oliveira PT; Rosa AL
Mol Cell Biochem; 2006 Apr; 285(1-2):101-9. PubMed ID: 16477374
[TBL] [Abstract][Full Text] [Related]
9. Purmorphamine enhances osteogenic activity of human osteoblasts derived from bone marrow mesenchymal cells.
Beloti MM; Bellesini LS; Rosa AL
Cell Biol Int; 2005 Jul; 29(7):537-41. PubMed ID: 15979909
[TBL] [Abstract][Full Text] [Related]
10. The effect of purmorphamine on osteoblast phenotype expression of human bone marrow mesenchymal cells cultured on titanium.
Beloti MM; Bellesini LS; Rosa AL
Biomaterials; 2005 Jul; 26(20):4245-8. PubMed ID: 15683647
[TBL] [Abstract][Full Text] [Related]
11. TAK-778 induces osteogenesis in ovariectomized rats via an estrogen receptor-dependent pathway.
Cai M; Yu Y; Feng S; Tao K; Li S; Deng L; Cai Z
J Bone Miner Metab; 2011 Mar; 29(2):168-73. PubMed ID: 20700613
[TBL] [Abstract][Full Text] [Related]
12. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
[TBL] [Abstract][Full Text] [Related]
13. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of estrogen and antiestrogens on differentiation of osteoblasts in mouse bone marrow culture.
Qu Q; Härkönen PL; Väänänen HK
J Cell Biochem; 1999 Jun; 73(4):500-7. PubMed ID: 10733344
[TBL] [Abstract][Full Text] [Related]
15. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
von Knoch F; Jaquiery C; Kowalsky M; Schaeren S; Alabre C; Martin I; Rubash HE; Shanbhag AS
Biomaterials; 2005 Dec; 26(34):6941-9. PubMed ID: 16009417
[TBL] [Abstract][Full Text] [Related]
16. Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway.
Tsai KS; Yang RS; Liu SH
Chem Res Toxicol; 2004 May; 17(5):679-84. PubMed ID: 15144225
[TBL] [Abstract][Full Text] [Related]
17. Ugonin K-stimulated osteogenesis involves estrogen receptor-dependent activation of non-classical Src signaling pathway and classical pathway.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2012 Feb; 676(1-3):26-33. PubMed ID: 22192930
[TBL] [Abstract][Full Text] [Related]
18. Behaviour of human osteoblastic cells cultured on plasma-sprayed titanium implants in the presence of nicotine.
Pereira ML; Carvalho JC; Peres F; Gutierres M; Fernandes MH
Clin Oral Implants Res; 2008 Jun; 19(6):582-9. PubMed ID: 18422986
[TBL] [Abstract][Full Text] [Related]
19. Effect of therapeutic levels of doxycycline and minocycline in the proliferation and differentiation of human bone marrow osteoblastic cells.
Gomes PS; Fernandes MH
Arch Oral Biol; 2007 Mar; 52(3):251-9. PubMed ID: 17141175
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements.
Tsigkou O; Jones JR; Polak JM; Stevens MM
Biomaterials; 2009 Jul; 30(21):3542-50. PubMed ID: 19339047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
